Montai Therapeutics, a company harnessing AI to decode untapped, diverse chemistry to develop breakthrough medicines for chronic disease, will present preclinical data for the first time on its novel ...
Nuclear factor erythroid 2-related factor 2 (NRF2) is a master regulator of cytoprotective mechanisms, and the cellular levels of this transcription factor are maintained low under normal conditions ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback